Organizations
Conferences
Info & Opinion
October 12, 2008
According to research firm Frost & Sullivan, the global outsourcing market is poised to get far larger, and fast.
Target Health has had good news this year, as the company’s Jules Mitchel relates of his EDC and document management systems.
The staffing company/CRO combo Trio Clinical Research takes on two equity partners and a C-level acquisition strategist from PRA International.
Feasibility studies are becoming more accepted, but misconceptions may also be proliferating. Thoughts from MDS Pharma.
Manhattan-based Clinilabs, started by a sleep researcher, has elected to expand into data management.
Many of the delays seen in trials these days originate in the start-up phase. The parties agree to get moving, and then a protocol is untenable, or the investigators can’t find as many patients as expected, or regulatory snafus appear. Chaos ensues. Feasibility studies can be a way to circumvent… more...
Looking for a contract research organization (CRO) that also has its own Phase I research facility? Well, you can try large firms like Quintiles, Parexel and MDS. Or you can call the relatively diminutive Clinilabs. Manhattan-based Clinilabs is one of the few—if not the only—small CRO with its own sizable… more...
Dude! Why now? Why ClinPhone? That was what we wanted to ask Josef von Rickenbach. Founder, chairman and CEO of Parexel, a contract research organization (CRO) with 7,300 employees, he recently offered $192 million for ClinPhone. It’s not clear at this writing if any other bidders will appear, or whether… more...
For the contract research organization (CRO) serving multiple clients, it can be tough to stay abreast of multiple projects all over the world. In many ways, the technology advances of the past few years have made this more onerous, not less. The sheer number of systems with vital data continues… more...
After being rebuffed earlier this year, Parexel reached deeply into its wallet to attempt to buy England’s ClinPhone. Price: $192 million. Some $300 million in debt will be raised to make the purchase possible; regulatory approval will also be required. Here’s a wire service story. It would be hard to… more...
After PharmaNet‘s (Nasdaq: PDGI) first quarter news that it had again lost $30 million in contracts—the same thing happened to the company in the last quarter of 2007—Standard and Poor’s (S&P’s) revised its outlook on the contract research organization (CRO) from stable to negative. It wasn’t just the loss of… more...
Every two weeks or so, Tim Schroeder gets a call from a fund manager or private equity group wanting to buy Clinical Trials and Consulting Services , the liver and transplant-focused contract research organization (CRO) he founded in Cincinnati almost a decade ago. “They say, ‘Hey, we want to buy… more...
Things aren’t going so great for Wayne, Pa.-based contract research organization (CRO) Encorium Group (Nasdaq: ENCO). In April, its CFO/executive vice president/secretary/general counsel for the last four years got hired away by Southborough, Mass.-based CRO Averion International (OTCBB: AVRO). Lawrence Hoffman stepped down May 2, and an interim CFO, Philip… more...
Independent accreditation in the clinical research world had been slow to catch on, but now it suddenly appears to be a topic of high interest. Compliance with existing regulations is not enough, it seems. Just take the numbers. In its first seven years of accrediting those in clinical research, the… more...
Research on the spine is where cardiac research was 10 years ago, declares Marcy Rogers. And that’s why she’s working hard to establish a presence in what she considers a soon-to-boom field. Enter, then, San Diego-based SpineMark CRO Management, the industry’s sole spine-only contract research organization (CRO), launched in 2005… more...